National Health Investors INC Form 4 insider transactions

Christian Ken Maingot, Chief Operating Officer of National Health Investors Inc, received 2,370 shares of common stock on July 27, 2026.

National Health Investors director Robert A. McCabe Jr. purchased 890 shares of common stock at $71.6485 per share.

National Health Investors director James R. Jobe reported a gift of 225 shares of common stock.

National Health Investors CEO D. Eric Mendelsohn purchased 1,500 shares of common stock at $68.84 per share.

National Health Investors Inc. CFO John L. Spaid reported a transaction involving the withholding of shares for tax obligations.

National Health Investors Inc. reports a transaction where CEO Eric Mendelsohn sold shares to cover tax obligations.

National Health Investors Inc. reports a transaction where SVP/Chief Accounting Officer Travis David L. acquired shares to cover tax obligations upon restricted stock vesting.

National Health Investors’ Chief Investment Officer Kevin Pascoe amended his Form 4 to correct a March 3, 2026 equity award to 4,726 shares, reducing a prior overstatement by 346 shares and confirming 73,082 shares held directly.

National Health Investors’ CFO John L. Spaid filed a Form 4/A to add 346 previously unreported shares from a March 3, 2026 stock award, bringing direct holdings to 56,600.637 shares.

National Health Investors director Lilly Donohue was granted 1,268 shares of common stock as a restricted award, vesting in March 2027.

National Health Investors director Tracy M.J. Colden received a grant of 1,268 shares of restricted common stock, which will vest in March 2027.

National Health Investors Inc. director Candice W. Todd received a grant of 1,268 restricted common shares, vesting in March 2027.

National Health Investors director Robert Chapin was granted 1,268 shares of restricted common stock, vesting in March 2027.

National Health Investors director James R. Jobe was granted 1,268 shares of restricted common stock, vesting in March 2027.

National Health Investors Director Robert A. McCabe Jr. received a grant of 1,268 restricted shares of common stock.

National Health Investors' CFO, John L. Spaid, increased his direct beneficial ownership through a restricted stock grant and option exercise, while also selling shares for tax obligations.

National Health Investors' Chief Investment Officer, Kevin Pascoe, was granted 5,072 shares of restricted common stock.

NATIONAL HEALTH INVESTORS INC CEO D. Eric Mendelsohn reported the acquisition of 14,409 restricted shares and disposition of 597 shares for tax purposes, alongside new stock option grants.

National Health Investors' SVP/Chief Accounting Officer, David L. Travis, was granted 3,458 restricted shares and had 411 shares withheld for tax purposes.

National Health Investors' SVP of Legal Affairs, Elizabeth Jackson Blankenship, received a grant of 2,420 restricted common shares.

National Health Investors' SVP/Chief Accounting Officer, David L. Travis, exercised stock options and subsequently sold a portion of the acquired shares.

National Health Investors' Chief Investment Officer, Kevin Carlton Pascoe, exercised stock options and subsequently sold shares to cover related tax obligations.

National Health Investors CEO D. Eric Mendelsohn exercised stock options and subsequently disposed of shares for tax obligations.

National Health Investors CFO John L. Spaid exercised stock options and subsequently sold shares to cover taxes, adjusting his beneficial ownership.

National Health Investors Director Tracy M. J. Colden exercised stock options and subsequently sold a portion of the acquired common stock.

National Health Investors CEO D. Eric Mendelsohn exercised stock options and increased his direct beneficial ownership of common stock.

National Health Investors Director James R. Jobe reported exercising stock options and subsequent sales of common stock, adjusting his beneficial ownership.

A director at National Health Investors Inc. exercised stock options and subsequently sold shares to cover related costs, adjusting their direct beneficial ownership.

National Health Investors' Chief Investment Officer, Kevin Carlton Pascoe, exercised stock options and subsequently sold a portion of the acquired shares.

National Health Investors' SVP/Chief Accounting Officer, David L. Travis, exercised stock options and subsequently disposed of shares for tax purposes, resulting in a net increase in directly held common stock.